Steven D. Harr
2023 - Sana Biotechnology
In 2023, Steven D. Harr earned a total compensation of $2.7M as President, Chief Executive Officer, and Director at Sana Biotechnology, a 30% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $377,001 |
|---|---|
| Option Awards | $1,631,250 |
| Salary | $659,411 |
| Other | $4,000 |
| Total | $2,671,662 |
Harr received $1.6M in option awards, accounting for 61% of the total pay in 2023.
Harr also received $377K in non-equity incentive plan, $659.4K in salary and $4K in other compensation.
Rankings
In 2023, Steven D. Harr's compensation ranked 354th out of 2,918 executives tracked by ExecPay. In other words, Harr earned more than 87.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 354 out of 2,918 | 88th |
Division Manufacturing | 205 out of 1,608 | 87th |
Major group Chemicals And Allied Products | 142 out of 901 | 84th |
Industry group Drugs | 139 out of 864 | 84th |
Industry Biological Products, Except Diagnostic Substances | 50 out of 211 | 76th |
Source: SEC filing on April 26, 2024.
Harr's colleagues
We found two more compensation records of executives who worked with Steven D. Harr at Sana Biotechnology in 2023.
News
Sana Biotechnology Former Executive Vice President and President, Research and Development Douglas Williams receives $3M in 2023
April 26, 2024
Sana Biotechnology General Counsel Bernard Cassidy receives $4M in 2022
April 28, 2023
Sana Biotechnology Chief Medical Officer Sunil Agarwal receives $1.9M in 2021
April 26, 2022